The role of insulin resistance in the longitudinal progression from NAFLD to cardiovascular-kidney-metabolic disease
Open Access
- 15 October 2025
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-10
Abstract
This study aimed to elucidate the role of insulin resistance in the progression from non-alcoholic fatty liver disease (NAFLD) to cardiovascular-kidney-metabolic (CKM) diseases, and to explore the potential influence of lifestyle factors. This study included participants free of NAFLD and CKM diseases from the UK Biobank. Insulin resistance was assessed using the TyG index. CKM diseases include ischemic stroke (IS), ischemic heart disease (IHD), type 2 diabetes (T2D), and chronic kidney disease (CKD). Markov multi-state models were used to assess the associations between the TyG index and disease transitions. Among 377,757 participants (median age 57 years), 4949 developed NAFLD over a median follow-up of 13.6 years. Of these, 12.65% progressed to T2D, 9.11% to IHD, 8.63% to CKD, and 4.61% to IS. Elevated TyG levels significantly accelerated transitions from NAFLD to first-onset CKM disease (HR = 1.25, 95% CI 1.05–1.49), double CKM disease (HR = 1.46, 95% CI 1.19–1.80), and triple CKM disease (HR = 1.81, 95% CI 1.28–2.55). Similar progression risk increases were observed for individual CKM components: T2D (HR = 1.41, 95% CI 1.11–1.78), CKD (HR = 1.37, 95% CI 1.08–1.75), and IS (HR = 1.70, 95% CI 1.27–2.27). A J-shaped dose–response relationship was identified. Transitions risk remained pronounced among individuals with healthy sleep and regular physical activity. Insulin resistance independently accelerated the progression from NAFLD to CKM diseases, particularly ischemic stroke. Healthy sleep and regular physical activity failed to offset this detrimental impact.Keywords
Funding Information
- National Natural Science Foundation of China (82501583, 82401551, U22A20341)
- Shenzhen High-level Hospital Construction Foundation (4004013)
- the China Postdoctoral Science Foundation (2025M772210)
This publication has 40 references indexed in Scilit:
- Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary careCardiovascular Diabetology, 2019
- Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistanceDiabetology & Metabolic Syndrome, 2018
- Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank StudyJAMA Cardiology, 2018
- Mechanistically different effects of fat and sugar on insulin resistance, hypertension, and gut microbiota in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2018
- The Global Epidemic of the Metabolic SyndromeCurrent Hypertension Reports, 2018
- A review of recent evidence relating to sugars, insulin resistance and diabetesEuropean Journal of Nutrition, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Nonalcoholic fatty liver diseaseNature Reviews Disease Primers, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- The mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks modelsComputer Methods and Programs in Biomedicine, 2010